All News

RheumNow Podcast square

Rheum Believe it Or Not (1.13.2023)

d Jack Cush, MD

Dr. Jack Cush reviews the notable standouts in the news since the 1st of January.  Surprising reports on ferritin, alcohol benefits, cannabis for pain and a lower dementia risk with hydroxychloroquine.  Here are the links below.

Read Article
alcohol%20glasses-919071__180.jpg (keep)

RA Disease Activity and Alcohol Use

d Jack Cush, MD

Despite its well known toxicities, alcohol is known to be antiinflammatory. The effects of alcohol use in rheumatoid arthritis (RA) is less known, but a recent study suggests that alcohol consumption was dose-dependently associated with lower disease activity and higher health-related quality of life in RA patients.

Read Article
pregnancy,doctor,consult

Worse Birth Outcomes in RA and SLE

d Jack Cush, MD

A population-based retrospective cohort study patients with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) and their infants demonstrated significant adverse pregnancy outcome, particularly the infants of women with SLE.

Read Article
pso.PsA_.NPF_.jpg

Bimekizumab in Active Psoriatic Arthritis - BE COMPLETE study

d Jack Cush, MD

BE COMPLETE is published, showing that bimekizumab (BMK), a selective dual inhibitor of interleukin (IL)-17F and IL-17A, results in superior improvement in both skin and joint outcomes in psoriatic arthritis (PsA) patients who have previously failed treatment with a tumour necrosis factor-α (TNFα) inhibitor.

Read Article
ACR GCA classification criteria tested in 676 patients suspected GCA (+US) - 276 dx w/ GCA; 400 not. Sensitivity was 87%, specificity 70%; 35 (13%) GCA pts did not meet criteria. & 119 non-GCA (30%) had ≥6 points (most PMR) https://t.co/bTrj83yM7l https://t.co/9iA8LbX6vB

Links:

Dr. John Cush RheumNow ( View Tweet)
Rheumatologists: What do you devote your weekends to?

Dr. John Cush RheumNow ( View Tweet)

2022 ACR Classification Criteria for GCA: (must be >50yrs) 6+ points needed for #GCA AM stiff should/neck +2 Visual loss +3 Jaw Claud +2 Temp HA +2 Scalp tender +2 Hi ESR/CRP +3 +Bx or US +5 axillary +2 +PEG Aorta +2 https://t.co/ZtVlYhpwru https://t.co/L1sv3L9p37

Links:

Dr. John Cush RheumNow ( View Tweet)
Register for RheumNow Live today and qualify for early bird pricing. Among our 24 speakers, Drs. Coates, Ruderman, and Champers will lead a session on the Modern Management of Psoriatic Arthritis. https://t.co/tiJssRdzAw https://t.co/Rar27hRahf

Links:

Dr. John Cush RheumNow ( View Tweet)
Population data on incidence of #RA from Northern Savo, Finland, 46 new RA cases in 2020; incidence seropos RA was 22.3 per 100K. Incidence did not differ by gender but decreased w/ age < 55 years, p = 0.003 (change in risk factors?) https://t.co/QxMwKh7wIU
Dr. John Cush RheumNow ( View Tweet)

Ferritin may be more than biomarker in Stills, etc - may contribute directly to pathogenesis. Ferritin causes PMN activation & neutrophil extracellular traps (NETs). Could this be targeted therapeutically? https://t.co/42KeTbVsQb https://t.co/imLipzmf4R

Links:

Dr. John Cush RheumNow ( View Tweet)
ACP Guidelines on Fracture Prevention in at-risk Adults The American College of Physicians (ACP) has updated its 2017 recommendations on pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults. https://t.co/FE6WEs1Oug https://t.co/Mvgx8sVLPh

Links:

Dr. John Cush RheumNow ( View Tweet)
Hosp study of 2809 admissions, found 1+adverse events (AE) in 24%. Among 978 AE, 23% (222) were preventable; 32% (316) serious. Preventable AE occurred in 1/15 admissions (serious 1/100). Drug AE were most common (39%) https://t.co/gqty53ccyH https://t.co/GxDBoEhxeM

Links:

Dr. John Cush RheumNow ( View Tweet)
JAK Inhibitor Promising for Polymyalgia Rheumatica Tofacitinib appeared highly effective against PMR in a small single-arm trial, researchers said, suggesting another potential alternative to long-term corticosteroids. https://t.co/XNhICcDU7t https://t.co/WWHNRP3aeP

Links:

Dr. John Cush RheumNow ( View Tweet)
"It takes alot of courage to reach out and say 'I need some help on this one'" (Carla Harris) Put on your big-boy pants, woman-up and ask for advice, not from anyone - go to the right person/people - you know who they are! https://t.co/GUs1nCvXeU
Dr. John Cush RheumNow ( View Tweet)
Holes in TH17 cells release IL-1α on NLRP3 activation Certain T cells can secrete cytokines that are normally part of the innate immune system, as researchers from the Leibniz-HKI and an international research team discovered. https://t.co/lLHD66D3RP https://t.co/cym7SGD2WX

Links:

Dr. John Cush RheumNow ( View Tweet)
Free great handout on DRESS - Drug Reaction With Eosinophilia and Systemic Symptoms. May affect adults or children; usually 2 to 8 weeks after beginning a medication. ~1 in 1000 taking specific drugs get DRESS. Allopurinol is a common cause https://t.co/X8lHtGVunC https://t.co/OjCzUXWJcz

Links:

Dr. John Cush RheumNow ( View Tweet)
anti-mitochondrial antibodies (AMA) in were assayed in 404 #RA patients & found to positive in 14-26%. Importantly AMA Abs were associated with erosive disease (p<0.05) and interstitial lung disease (p<0.01), independent of CCP or RF https://t.co/ZcrOYr0cWX https://t.co/KvZ3N5IiCB

Links:

Dr. John Cush RheumNow ( View Tweet)
10 best US jobs in2023, half are medical 1 Software developer 2 Nurse practioner 3 Medical/health serv manager 4 Physician asst 5 Information security analyst 6 Physical therapist 7 Financial manager 8 IT Manager 9 Web developer 10 Dentist https://t.co/nL5yuorzTH https://t.co/4mYspRCZX0

Links:

Dr. John Cush RheumNow ( View Tweet)
Cannabis Use for Pain is Common In states with legalized medical cannabis use, 3 in 10 persons are using cannabis to manage their pain. https://t.co/XUt1E7GcQN https://t.co/4l6vYKUOQs

Links:

Dr. John Cush RheumNow ( View Tweet)
Treatment Considerations in Axial Spondyloarthritis https://t.co/GRQfk4B4QN https://t.co/xX5AYAD90c

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×